Merck KGaA (ETR:MRK) Shares Down 0.5% – Here’s Why

Merck KGaA (ETR:MRK) traded down 0.5% during mid-day trading on Thursday . The stock traded as low as €138.45 and last traded at €138.65. 112,448 shares traded hands during mid-day trading, The stock had previously closed at €139.35.

Merck KGaA Price Performance

The firm has a market capitalization of $61.75 billion, a PE ratio of 22.78, a P/E/G ratio of 2.37 and a beta of 0.81. The company has a current ratio of 1.69, a quick ratio of 0.72 and a debt-to-equity ratio of 40.77. The company has a fifty day moving average price of €140.43 and a two-hundred day moving average price of €126.66.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.